- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
New measurement for hepatitis B unveiled
2012/02/19 21:17:21 Taipei, Feb. 19 (CNA) A Taiwanese liver disease research team introduced on Sunday a new measurement that helps to better diagnose hepatitis B infections, which affect roughly 2.5 million people in Taiwan, and gauge whether they are under control.
The REVEAL–HBV Study Group, led by Chen Chien-jen, unveiled the new measurement at an annual meeting of the Asian Pacific Association for the Study of the Liver (APASL) in Taipei.
The new measurement detects the amount of hepatitis B surface antigens (HBsAg) in a person's body. The antigens are proteins produced by the hepatitis B virus (HBV) that peak with the first appearance of clinical disease symptoms.
The new measurement reveals how a hepatitis B carrier's immune system responds to the virus and helps doctors evaluate the effectiveness of certain medications, according to Kao Jia-horng, APASL chief and a professor at National Taiwan University's College of Medicine.
Chen, an academician at Academia Sinica, Taiwan's top research institution, said that the new measurement complements existing gauges measuring the amount of hepatitis B virus DNA and will help doctors more accurately assess the risk of hepatitis B infections developing into liver cirrhosis and liver cancer.
Liaw Yun-fan, another academician at the meeting, said that a growing body of research shows the amount of HBsAg is indrectly related to how hepatitis B infections come under control.
Liaw said the lower the HBsAg level, the more the infection is under control.
Among the other existing measurements for hepatitis B infections are age, sex, and liver function index.
(By Chen Ching-fang and Scully Hsiao)
enditem/ls
B型肝炎推出了新的测量
2012年2月19日21时十七分21秒
台北,2月19日(中央社)上周日推出了一个新的测量,有助于更好地诊断乙肝感染,这会影响大约250万台湾人民,了解他们是否受到控制的一个台湾人的肝脏疾病的研究团队。
肝脏研究亚太协会的年度会议(APASL)在台北亮相的Reveal-HBV研究小组,由陈建仁率领新的测量。
新的测量检测乙肝表面抗原(HBsAg)的数量在一个人的身体。抗原是由乙型肝炎病毒(HBV)产生的蛋白质与临床疾病症状首次出现的高峰期。
新的测量显示,B型肝炎病毒载体的免疫系统如何响应病毒,并帮助医生评估了某些药物的有效性,根据高嘉鸿,在的APASL行政和台大医学院教授。
陈,在中国科学院中央研究院,台湾的顶级研究机构,院士说,新的测量补充乙肝病毒DNA量测量现有的仪表和有助医生更准确地评估肝炎乙发展成肝硬化和肝癌的感染的风险。
风扇,另院士在会上,廖云说,越来越多的研究显示HBsAg的量indrectly涉及到如何控制乙型肝炎感染。
廖说,HBsAg水平较低,更多的感染控制。
其中B型肝炎感染的其他现有测量年龄,性别,肝功能指数。
(陈清芳和Scully萧)
(完)/ LS
|
|